Kodiak Sciences Net Income
| KOD Stock | USD 22.07 0.07 0.32% |
As of the 15th of February 2026, Kodiak Sciences secures the Mean Deviation of 4.04, downside deviation of 4.45, and Risk Adjusted Performance of 0.0711. Kodiak Sciences technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kodiak Sciences treynor ratio, and the relationship between the standard deviation and downside variance to decide if Kodiak Sciences is priced some-what accurately, providing market reflects its recent price of 22.07 per share. Given that Kodiak Sciences has jensen alpha of 0.2721, we recommend you to check Kodiak Sciences's last-minute market performance to make sure the company can sustain itself at a future point.
Kodiak Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kodiak Sciences' valuation are provided below:There are over one hundred nineteen available fundamental ratios for Kodiak Sciences, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Kodiak Sciences' last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of February 15, 2026, Market Cap is expected to decline to about 378.4 M. In addition to that, Enterprise Value is expected to decline to about 196.6 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -158.6 M | -166.5 M | |
| Net Loss | -300.4 M | -285.4 M | |
| Net Loss | -158.6 M | -166.5 M | |
| Net Loss | (3.85) | (4.05) |
Kodiak | Net Income | Build AI portfolio with Kodiak Stock |
Analyzing Kodiak Sciences's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Kodiak Sciences's current valuation and future prospects.
Latest Kodiak Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of Kodiak Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Kodiak Sciences financial statement analysis. It represents the amount of money remaining after all of Kodiak Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Kodiak Sciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kodiak Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (176.21 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Kodiak Net Income Regression Statistics
| Arithmetic Mean | (101,904,524) | |
| Coefficient Of Variation | (104.80) | |
| Mean Deviation | 92,044,382 | |
| Median | (41,443,000) | |
| Standard Deviation | 106,793,144 | |
| Sample Variance | 11404.8T | |
| Range | 316.7M | |
| R-Value | (0.77) | |
| Mean Square Error | 4995.2T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | (16,235,757) | |
| Total Sum of Squares | 182476.4T |
Kodiak Net Income History
Other Fundumenentals of Kodiak Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Kodiak Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Kodiak Sciences is extremely important. It helps to project a fair market value of Kodiak Stock properly, considering its historical fundamentals such as Net Income. Since Kodiak Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kodiak Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kodiak Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Kodiak diversify its offerings? Factors like these will boost the valuation of Kodiak Sciences. Expected growth trajectory for Kodiak significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Kodiak Sciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Kodiak Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Kodiak Sciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Kodiak Sciences' market price to deviate significantly from intrinsic value.
Understanding that Kodiak Sciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kodiak Sciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Kodiak Sciences' market price signifies the transaction level at which participants voluntarily complete trades.
Kodiak Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kodiak Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kodiak Sciences.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Kodiak Sciences on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Kodiak Sciences or generate 0.0% return on investment in Kodiak Sciences over 90 days. Kodiak Sciences is related to or competes with Nurix Therapeutics, Xencor, Phathom Pharmaceuticals, Oculis Holding, Eyepoint Pharmaceuticals, UroGen Pharma, and AnaptysBio. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics ... More
Kodiak Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kodiak Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kodiak Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.45 | |||
| Information Ratio | 0.0639 | |||
| Maximum Drawdown | 23.68 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 9.66 |
Kodiak Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kodiak Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kodiak Sciences' standard deviation. In reality, there are many statistical measures that can use Kodiak Sciences historical prices to predict the future Kodiak Sciences' volatility.| Risk Adjusted Performance | 0.0711 | |||
| Jensen Alpha | 0.2721 | |||
| Total Risk Alpha | 0.0075 | |||
| Sortino Ratio | 0.0723 | |||
| Treynor Ratio | 0.2088 |
Kodiak Sciences February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0711 | |||
| Market Risk Adjusted Performance | 0.2188 | |||
| Mean Deviation | 4.04 | |||
| Semi Deviation | 3.97 | |||
| Downside Deviation | 4.45 | |||
| Coefficient Of Variation | 1286.08 | |||
| Standard Deviation | 5.04 | |||
| Variance | 25.38 | |||
| Information Ratio | 0.0639 | |||
| Jensen Alpha | 0.2721 | |||
| Total Risk Alpha | 0.0075 | |||
| Sortino Ratio | 0.0723 | |||
| Treynor Ratio | 0.2088 | |||
| Maximum Drawdown | 23.68 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 9.66 | |||
| Downside Variance | 19.83 | |||
| Semi Variance | 15.78 | |||
| Expected Short fall | (4.40) | |||
| Skewness | 0.4025 | |||
| Kurtosis | (0.21) |
Kodiak Sciences Backtested Returns
Kodiak Sciences appears to be not too volatile, given 3 months investment horizon. Kodiak Sciences has Sharpe Ratio of 0.0587, which conveys that the firm had a 0.0587 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Kodiak Sciences, which you can use to evaluate the volatility of the firm. Please exercise Kodiak Sciences' Downside Deviation of 4.45, risk adjusted performance of 0.0711, and Mean Deviation of 4.04 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kodiak Sciences holds a performance score of 4. The company secures a Beta (Market Risk) of 1.83, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kodiak Sciences will likely underperform. Please check Kodiak Sciences' downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Kodiak Sciences' current price movements will revert.
Auto-correlation | -0.64 |
Very good reverse predictability
Kodiak Sciences has very good reverse predictability. Overlapping area represents the amount of predictability between Kodiak Sciences time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kodiak Sciences price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Kodiak Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | -0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 4.54 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Kodiak Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Kodiak Sciences reported net income of (176.21 Million). This is 151.63% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 130.86% higher than that of the company.
Kodiak Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kodiak Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kodiak Sciences could also be used in its relative valuation, which is a method of valuing Kodiak Sciences by comparing valuation metrics of similar companies.Kodiak Sciences is currently under evaluation in net income category among its peers.
Kodiak Sciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Kodiak Sciences from analyzing Kodiak Sciences' financial statements. These drivers represent accounts that assess Kodiak Sciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Kodiak Sciences' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.3B | 878.3M | 374.1M | 523.2M | 470.9M | 378.4M | |
| Enterprise Value | 476.9M | 326.8M | 371.4M | 425.5M | 382.9M | 196.6M |
Kodiak Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Kodiak Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Kodiak Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Kodiak Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Kodiak Sciences that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Kodiak Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Kodiak Sciences' value.| Shares | Board Of Ttees Leland Stanford Jr Univ | 2025-06-30 | 691.8 K | D. E. Shaw & Co Lp | 2025-06-30 | 601.6 K | Ikarian Capital, Llc | 2025-06-30 | 599.5 K | Nantahala Capital Management, Llc | 2025-06-30 | 590.9 K | Point72 Asset Management, L.p. | 2025-06-30 | 452.7 K | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 420.7 K | Silverarc Capital Management, Llc | 2025-06-30 | 401.5 K | Northern Trust Corp | 2025-06-30 | 344.6 K | Bruce & Co Inc | 2025-06-30 | 323 K | Baker Bros Advisors Lp | 2025-06-30 | 17.3 M | Blackrock Inc | 2025-06-30 | 3.6 M |
Kodiak Fundamentals
| Return On Equity | -2.08 | ||||
| Return On Asset | -0.47 | ||||
| Current Valuation | 1.34 B | ||||
| Shares Outstanding | 61.05 M | ||||
| Shares Owned By Insiders | 4.77 % | ||||
| Shares Owned By Institutions | 82.48 % | ||||
| Number Of Shares Shorted | 7.32 M | ||||
| Price To Earning | (2.29) X | ||||
| Price To Book | 56.77 X | ||||
| EBITDA | (149.5 M) | ||||
| Net Income | (176.21 M) | ||||
| Cash And Equivalents | 597.88 M | ||||
| Cash Per Share | 11.55 X | ||||
| Total Debt | 70.34 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 8.65 X | ||||
| Book Value Per Share | 0.45 X | ||||
| Cash Flow From Operations | (117.32 M) | ||||
| Short Ratio | 8.96 X | ||||
| Earnings Per Share | (4.12) X | ||||
| Price To Earnings To Growth | (0.08) X | ||||
| Target Price | 35.5 | ||||
| Number Of Employees | 123 | ||||
| Beta | 2.65 | ||||
| Market Capitalization | 1.35 B | ||||
| Total Asset | 335.58 M | ||||
| Retained Earnings | (1.33 B) | ||||
| Working Capital | 146.36 M | ||||
| Current Asset | 7.31 M | ||||
| Current Liabilities | 4.89 M | ||||
| Net Asset | 335.58 M |
About Kodiak Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kodiak Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kodiak Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kodiak Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:Check out For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Biotechnology sector continue expanding? Could Kodiak diversify its offerings? Factors like these will boost the valuation of Kodiak Sciences. Expected growth trajectory for Kodiak significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Kodiak Sciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Kodiak Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Kodiak Sciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Kodiak Sciences' market price to deviate significantly from intrinsic value.
Understanding that Kodiak Sciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kodiak Sciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Kodiak Sciences' market price signifies the transaction level at which participants voluntarily complete trades.